PMC9226564_01
Case 2: Follow-up of patient body weight over a 36-month period, including cessation of AZA intake.
fimmu-13-903012-g002.jpg
PMC9226564_01_fimmu-13-903012-g002.jpg
f2
The  Figure 2  shows the results for a 28-year-old male Brazilian renal transplant patient on AZA plus, prednisone with normal renal function (creatinine 1.2 mg/dL), who presented with persistent diarrhea for two years, accompanied by a significant reduction in body weight.
PMC9226564_02
PMC9226564_03